Andersons

Andersons Inc receives a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 10% premium over our quantitative fair value estimate of $61.09 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The company's balance sheet undermines our valuation estimate. Low leverage can limit a company's ability to invest in growth, potentially reducing shareholder value compared with a balanced use of debt and equity financing. For example, the firm's debt to EBITDA ratio of 2.4 lies in the bottom 45% compared with global peers. With little debt relative to assets, this firm has a "lazy" balance sheet, which can depress returns on invested capital. We believe this is a sign that shares could be expensive.

On a different note, the company's valuation metrics are reassuring. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to EBITDA ratio of 7.1, a core component of valuation, lies in the bottom 30% compared with global peers. Relative to the company's EBITDA, the enterprise value of the business is low, which, despite our unfavorable price/fair value ratio, is a positive attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.